Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy
ICD-10 E09.44 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy.
E09.44 refers to diabetes mellitus that is induced by drugs or chemicals, specifically characterized by neurological complications such as diabetic amyotrophy. This condition arises when certain medications or toxic substances lead to insulin resistance or impaired insulin secretion, resulting in hyperglycemia. Diabetic amyotrophy is a specific complication that manifests as muscle weakness and pain, primarily affecting the proximal muscles of the lower limbs. Patients may experience significant discomfort and functional impairment due to this condition. Management of E09.44 involves careful monitoring of blood glucose levels, typically assessed through HbA1c testing, which provides an average of blood glucose levels over the past two to three months. Insulin therapy may be necessary to control hyperglycemia, especially in cases where oral hypoglycemic agents are ineffective. The presence of neurological complications necessitates a multidisciplinary approach to treatment, including physical therapy and pain management strategies to address the symptoms of diabetic amyotrophy.
Detailed medication history, HbA1c levels, and treatment plans.
Management of patients with drug-induced diabetes and associated complications.
Ensure accurate documentation of the specific drug causing diabetes and its effects.
Neurological assessments, symptom descriptions, and treatment responses.
Evaluation of patients presenting with diabetic amyotrophy.
Document the neurological examination findings and their correlation with diabetes.
Used for follow-up visits for diabetes management.
Document patient's history, examination findings, and treatment plan.
Endocrinologists should focus on medication adjustments and complications.
Common drugs that can induce diabetes include corticosteroids, certain antipsychotics, and some chemotherapy agents. It is crucial to document the specific medication responsible for accurate coding.
